Press release
Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Trends Support A 13.3% CAGR Outlook Through The Forecast Period
Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market
Growth Outlook and Market Size for Temperature-Stable mRNA Vials
The market for temperature-stable mRNA vials has experienced swift growth over recent years. From a valuation of $2.01 billion in 2025, it is projected to reach $2.28 billion in 2026, registering a compound annual growth rate (CAGR) of 13.6%. This upward trend is driven by the expansion of mRNA vaccine research, heightened investments in lipid nanoparticle technologies, the strengthening of global immunization programs, challenges related to cold-chain logistics, and early adoption of stabilized mRNA delivery systems.
Download a free sample of the temperature-stable messenger ribonucleic acid (mrna) vial market report:
https://thebusinessresearchcompany.com/sample_request?id=52041952&type=smp&name=Temperature-Stable%C2%A0Messenger%20Ribonucleic%20Acid%20%28mRNA%29%C2%A0Vial%20Market%20Report%202026&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Oct_PR
Looking ahead, the market is expected to accelerate further, aiming for $3.77 billion by 2030 with a CAGR of 13.3%. The forecasted growth is supported by rising demand for next-generation mRNA therapeutics, growing emphasis on making vaccines widely accessible worldwide, development of decentralized healthcare models, increasing investments in temperature-stable biologics, and more regulatory approvals of mRNA-based products. Key trends shaping the future include the creation of thermostable mRNA formulations, wider use of lyophilized mRNA vials, demand for cold-chain independent storage solutions, expansion of worldwide mRNA distribution initiatives, and a stronger focus on packaging durability and stability.
Leading Companies Driving the Temperature-Stable mRNA Vial Market
Prominent organizations steering the temperature-stable mRNA vial sector include:
Arcturus Therapeutics Holdings Inc., CureVac AG, Sanofi S.A., Lonza Group AG, Gerresheimer AG, Stevanato Group, Schott AG, CSafe Global, Gennova Biopharmaceuticals Ltd., TTP Group, Peli BioThermal LLC, SiO2 Materials Science, Shijiazhuang Xinfuda Medical Packaging, Vaxess Technologies, Ethris, Lyophilization Techniques, 20Med Therapeutics BV, EnsiliTech, HDT Bio Corp., and Emervax.
View the full temperature-stable messenger ribonucleic acid (mrna) vial market report:
https://www.thebusinessresearchcompany.com/report/temperature-stable messenger-ribonucleic-acid-mrna vial-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Oct_PR
In a notable partnership formed in February 2023, Netherlands-based 20Med Equipment Solutions Private Limited collaborated with the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate the development of RNA and DNA vaccines and therapeutics. Their joint efforts focus on advancing bio-responsive nanoparticle technology to eliminate the need for frozen storage of mRNA vaccines, thereby boosting global vaccine accessibility. CEPI, headquartered in Norway, actively supports innovations like temperature-stable mRNA vials to enhance vaccine storage, distribution, and accessibility on a global scale.
Emerging Trends in Innovation and Manufacturing Approaches
Companies in this market are concentrating on new strategies to increase manufacturing efficiency, expand production capacity globally, and improve vaccine accessibility, especially in low- and middle-income countries. One significant method involves technology transfer models, which help share expertise, skills, and manufacturing techniques across organizations to enable local production and broader distribution.
For instance, in January 2024, Germany-based SCHOTT Pharma introduced EVERIC freeze vials, designed to endure temperatures as low as -80°C. These vials are suitable for vaccines and treatments such as mRNA therapies and gene therapies targeting infectious diseases, cancer, and central nervous system disorders. Their design minimizes the risk of breakage, reducing the chances of losing valuable medications and costly production downtime.
Detailed Breakdown of the Temperature-Stable mRNA Vial Market Segmentation
This market can be segmented into the following categories:
1) Product Type:
- Lipid Nanoparticle Formulations
- Polymer-Based Formulations
- Lyophilized Messenger Ribonucleic Acid (mRNA) Vials
- Other Product Types
2) Distribution Channel:
- Direct Sales
- Distributors
- Online Sales
- Other Distribution Channels
3) Applications:
- Vaccines
- Therapeutics
- Research
- Other Applications
4) End Users:
- Hospitals and Clinics
- Research Institutes
- Pharmaceutical and Biotechnology Companies
- Other End Users
Sub-segmentation includes:
- Lipid Nanoparticle Formulations: Cationic, Ionizable, and Neutral Lipid Nanoparticles
- Polymer-Based Formulations: Polyethylene Glycol-Based, Polymeric Micelles, and Dendrimer-Based Formulations
- Lyophilized mRNA Vials: Single-Dose and Multi-Dose Vials
- Other Product Types: Peptide-Based, Protein-Based, and Hybrid Formulations
This comprehensive segmentation reflects the diverse technological approaches and distribution methods within the temperature-stable mRNA vial market, emphasizing its broad applicability in modern healthcare.
Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Trends Support A 13.3% CAGR Outlook Through The Forecast Period here
News-ID: 4675225 • Views: …
More Releases from The Business Research Company
Toxicology Drug Screening Market Analysis Highlights Growth To $33.48 Billion By …
The toxicology drug screening market has demonstrated robust growth in recent years, driven by various technological and regulatory factors. This sector is poised for further expansion as advancements in testing methods and data management continue to evolve. Here's an in-depth look at the market size, key players, growth drivers, major trends, and segment analysis shaping the future of toxicology drug screening.
Market Size and Growth Trajectory of the Toxicology Drug Screening…
Tissue Regeneration Scaffold Market Study Explores Industry Growth Toward $5.58 …
The tissue regeneration scaffold market is witnessing impressive growth fueled by advancements in medical technology and increasing demand for innovative treatment options. This sector holds promising opportunities as new materials and fabrication techniques continue to emerge, enhancing the effectiveness and application scope of scaffolds in regenerative medicine.
Projected Size and Growth Trajectory of the Tissue Regeneration Scaffold Market
The tissue regeneration scaffold market has experienced rapid expansion in recent years. It…
Thrombophilia Market Research Explores Growth Within A $26.5 Billion Opportunity
The thrombophilia market has witnessed substantial growth in recent years and continues to expand rapidly due to advancements in medical diagnostics and treatment options. This increasing momentum is driven by numerous factors, including rising awareness of inherited blood disorders and technological innovations that are transforming patient care. Below is an in-depth look at the market's current size, key drivers, leading companies, emerging trends, and segmentation.
Forecasted Expansion of the Thrombophilia Market…
T Cell Surface Glycoprotein CD3 Epsilon Chain Market Report 2026 Market Outlook …
The T Cell Surface Glycoprotein CD3 Epsilon Chain market is gaining momentum as research and therapeutic applications expand rapidly. Understanding its current size, growth drivers, key players, and emerging trends provides valuable insight into this evolving sector. Here, we explore the market's development, influential factors, major companies, innovations, and segmentation.
Market Size and Projected Growth for the T Cell Surface Glycoprotein CD3 Epsilon Chain Market
In recent years, the market for…
More Releases for RNA
Small Interfering RNA (siRNA) Therapeutics Market Growth (2026-2033) | RNA Drugs …
DataM Intelligence has released a new research report titled "Small Interfering RNA (siRNA) Therapeutics Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market…
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
